Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3b
- 31 December 1983
- journal article
- Published by Elsevier BV in Molecular Immunology
- Vol. 20 (12), 1401-1404
- https://doi.org/10.1016/0161-5890(83)90172-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Structural Determinants of the Capacity of Heparin to Inhibit the Formation of the Human Amplification C3 ConvertaseJCI Insight, 1981
- Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.The Journal of Experimental Medicine, 1979
- Solvolytic desulfation of glycosaminoglycuronan sulfates with dimethyl sulfoxide containing water or methanolCarbohydrate Research, 1977
- Mode of interaction of different polyanions with the first (C1, CImmunochemistry, 1976
- Mode of interaction of different polyanions with the first (Immunochemistry, 1976
- Mode of interaction of different polyanions with the first (Immunochemistry, 1976
- Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.The Journal of Experimental Medicine, 1975
- Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serumImmunochemistry, 1966
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949
- Anticomplementary Power of HeparinThe Journal of Infectious Diseases, 1929